![Dominik Höchli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominik Höchli
Directeur/Membre du Conseil chez
MOLECULAR PARTNERS AG
Fortune : 20 021 $ au 31/05/2026
Profil
Currently, Dominik Höchli is an Independent Non-Executive Director at Molecular Partners AG since 2021 and a Director at Abivax SA starting in 2025.
Formerly, Dr. Höchli was Co-Managing Director at Catapult Therapeutics BV from 2021 to 2025 and Vice President & Head-Global Medical Affairs at AbbVie AG.
Education includes a doctorate from the University of Bern.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MOLECULAR PARTNERS AG 0,01 % | 31/12/2025 | 4 982 ( 0,01 % ) | 20 021 $ | 31/05/2026 |
Postes actifs de Dominik Höchli
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULAR PARTNERS AG | Directeur/Membre du Conseil | 21/04/2021 |
| ABIVAX | Directeur/Membre du Conseil | 22/04/2025 |
Anciens postes connus de Dominik Höchli
| Sociétés | Poste | Fin |
|---|---|---|
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Directeur Général | 22/04/2025 |
AbbVie AG
 AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Directeur Technique/Scientifique/R&D | - |
Formation de Dominik Höchli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
AbbVie AG
AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Commercial Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Commercial Services |
